Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""CCNE1"" wg kryterium: Temat


Tytuł :
Genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 are associated with ovarian cancer susceptibility among Chinese Han women.
Autorzy :
Zheng L; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, PR China.
Song A
Ruan Y
Chen L
Liu D
Li X
Guo H
Han J
Li Y
Tian X
Fang W
Pokaż więcej
Źródło :
Cancer epidemiology [Cancer Epidemiol] 2013 Oct; Vol. 37 (5), pp. 639-46. Date of Electronic Publication: 2013 Jun 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genes, BRCA1*
Asian Continental Ancestry Group/*genetics
Aurora Kinase A/*genetics
Cyclin E/*genetics
Cyclin-Dependent Kinase 2/*genetics
Cystadenocarcinoma, Serous/*genetics
Oncogene Proteins/*genetics
Ovarian Neoplasms/*genetics
Case-Control Studies ; China ; Female ; Genetic Predisposition to Disease ; HapMap Project ; Humans ; Middle Aged ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł :
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.
Autorzy :
Pils D; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria. Electronic address: .
Bachmayr-Heyda A; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
Auer K; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
Svoboda M; Department of Pathophysiology and Allergy Research, Center of Pathophysiology Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Auner V; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
Hager G; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
Obermayr E; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Cluster 'Translational Oncology', General Hospital Vienna, Vienna, Austria.
Reiner A; Institute for Pathology, Danube Hospital, Vienna, Austria.
Reinthaller A; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
Speiser P; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
Braicu I; Department of Gynecology, Campus Virchow Klinikum, Charité Medical University, Berlin, Germany.
Sehouli J; Department of Gynecology, Campus Virchow Klinikum, Charité Medical University, Berlin, Germany.
Lambrechts S; Department of Obstetrics and Gynecology, Division of Gynecological Oncology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium.
Vergote I; Department of Obstetrics and Gynecology, Division of Gynecological Oncology, University Hospitals Leuven, Katholieke Universiteit Leuven, Leuven, Belgium.
Mahner S; Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, MUMC+, GROW - School for Oncology and Developmental Biology, Maastricht, The Netherlands.
Berger A; Department of Gynecology and Obstetrics, Medical University Innsbruck, Innsbruck, Austria.
Cacsire Castillo-Tong D; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria.
Zeillinger R; Department of Obstetrics and Gynecology, Molecular Oncology Group, Medical University of Vienna, Vienna, Austria; Ludwig Boltzmann Cluster 'Translational Oncology', General Hospital Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2014 Jan; Vol. 50 (1), pp. 99-110. Date of Electronic Publication: 2013 Oct 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*genetics
Cyclin E/*genetics
Neoplasms, Glandular and Epithelial/*genetics
Oncogene Proteins/*genetics
Ovarian Neoplasms/*genetics
Biomarkers, Tumor/metabolism ; Carcinoma, Ovarian Epithelial ; Cell Proliferation ; Cyclin E/metabolism ; Cyclins/genetics ; Cyclins/metabolism ; Female ; Gene Amplification ; Gene Dosage ; Gene Expression ; Humans ; Middle Aged ; Neoplasms, Glandular and Epithelial/metabolism ; Oncogene Proteins/metabolism ; Ovarian Neoplasms/metabolism ; Prognosis ; Signal Transduction
Czasopismo naukowe
Tytuł :
Global Gene Expression Profiling Identifies ALDH2, CCNE1 and SMAD3 as Potential Prognostic Markers in Upper Tract Urothelial carcinoma
Index Terms :
Upper tract urothelial carcinoma of renal pelvis
Global gene expression profiling
ALDH2
CCNE1
SMAD3
Prognosis
Article
URL :
http://repository.ust.hk/ir/Record/1783.1-67801">http://repository.ust.hk/ir/Record/1783.1-67801
http://lbdiscover.ust.hk/uresolver?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/HKUST:SPI&rft.genre=article&rft.issn=1471-2407&rft.volume=14&rft.issue=&rft.date=2014&rft.spage=&rft.aulast=Wu&rft.aufirst=Song%7C&rft.atitle=Global%20Gene%20Expression%20Profiling%20Identifies%20ALDH2%2C%20CCNE1%20and%20SMAD3%20as%20Potential%20Prognostic%20Markers%20in%20Upper%20Tract%20Urothelial%20carcinoma&rft.title=BMC%20Cancer">http://lbdiscover.ust.hk/uresolver?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/HKUST:SPI&rft.genre=article&rft.issn=1471-2407&rft.volume=14&rft.issue=&rft.date=2014&rft.spage=&rft.aulast=Wu&rft.aufirst=Song%7C&rft.atitle=Global%20Gene%20Expression%20Profiling%20Identifies%20ALDH2%2C%20CCNE1%20and%20SMAD3%20as%20Potential%20Prognostic%20Markers%20in%20Upper%20Tract%20Urothelial%20carcinoma&rft.title=BMC%20Cancer
http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=LinksAMR&SrcApp=PARTNER_APP&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000345161600001">http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=LinksAMR&SrcApp=PARTNER_APP&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000345161600001
http://www.scopus.com/record/display.url?eid=2-s2.0-84965094275&origin=inward">http://www.scopus.com/record/display.url?eid=2-s2.0-84965094275&origin=inward
Zasób elektroniczny
Tytuł :
Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer.
Autorzy :
Colombo PE; Department of Surgical Oncology, Montpellier Cancer Institute (ICM), 34298 Montpellier, France. Electronic address: .
Fabbro M; Departement of Medical Oncology, Montpellier Cancer Institute (ICM), 34298 Montpellier, France.
Theillet C; Identity and Tumoral Plasticity, (INSERM U896), Research Cancer Institute IRCM Montpellier Cancer Institute, 34298 Montpellier, France.
Bibeau F; Department of pathology, Montpellier Cancer Institute (ICM), 34298 Montpellier, France.
Rouanet P; Department of Surgical Oncology, Montpellier Cancer Institute (ICM), 34298 Montpellier, France.
Ray-Coquard I; Departement of Medical Oncology, Centre Léon Bérard, 69008 Lyon, France.
Pokaż więcej
Źródło :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2014 Feb; Vol. 89 (2), pp. 207-16. Date of Electronic Publication: 2013 Sep 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Neoplasms, Glandular and Epithelial/*drug therapy
Neoplasms, Glandular and Epithelial/*pathology
Organoplatinum Compounds/*therapeutic use
Ovarian Neoplasms/*drug therapy
Ovarian Neoplasms/*pathology
Ovary/*drug effects
Ovary/*pathology
Animals ; Carcinoma, Ovarian Epithelial ; DNA Repair/drug effects ; Drug Resistance, Neoplasm ; Female ; Humans ; Neoplasms, Glandular and Epithelial/genetics ; Ovarian Neoplasms/genetics ; Ovary/metabolism
Czasopismo naukowe
Tytuł :
Association of genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 with the risk of endometrial carcinoma and clinicopathological parameters among Chinese Han women.
Autorzy :
Zheng LY; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, People's Republic of China.
Song AP; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, People's Republic of China.
Chen L; Department of Pathology, Beijing Hospital, Beijing, People's Republic of China.
Liu DG; Department of Pathology, Beijing Hospital, Beijing, People's Republic of China.
Li XH; Department of Pathology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, People's Republic of China.
Guo HY; Department of Gynecology, Peking University Third Hospital, Beijing, People's Republic of China.
Tian XX; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, People's Republic of China. Electronic address: .
Fang WG; Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), School of Basic Medical Sciences, Peking University Health Science Center, Beijing, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2015 Jan; Vol. 184, pp. 65-72. Date of Electronic Publication: 2014 Nov 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Predisposition to Disease*
Adenocarcinoma/*genetics
Aurora Kinase A/*genetics
BRCA1 Protein/*genetics
Cyclin E/*genetics
Cyclin-Dependent Kinase 2/*genetics
Endometrial Neoplasms/*genetics
Oncogene Proteins/*genetics
Adenocarcinoma/pathology ; Alleles ; Asian Continental Ancestry Group/genetics ; Case-Control Studies ; China ; Disease Progression ; Endometrial Neoplasms/pathology ; Female ; Genetic Association Studies ; Genotype ; Haplotypes ; Humans ; Middle Aged ; Polymorphism, Single Nucleotide
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies